English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

This study aimed to investigate the short-term effects of Highly Active Antiretroviral Therapy (HAART) (stavudine, lamivudine and nevirapine) on serum lipids of HIV-1 positive subjects in Benin City, Nigeria. Test group 1 (n=78) and test group 2 (n= 71) comprised HIV- 1 seropositive individuals on HAART for a period of one to three months; and five to six months respectively. Fifty five newly diagnosed HIV-1 positive subjects naive to HAART served as control group 1 and sixty apparently healthy HIV-1 seronegative individuals served as control group 2. The blood samples obtained were analyzed for total cholesterol, triglycerides, low-density lipoprotein and high-density lipoprotein using standard enzymatic methods. Total cholesterol of test group 2 (214.0±6.43mg/dL) was not significantly different from Test group 1 (202.4±5.09mg/dL), both were however significantly higher than control group 1 (159.3±5.09mg/dL) and control group 2 (101.6±3.76 mg/dL). Triglyceride concentration of test group 2 (106.6+11.95mg/dL) was not significantly different from test group 1 (135.8+9.88mg/dL), but were significantly different from control groups 1 and 2 (125.1+3.35mg/dL and 104.6+3.08mg/dL) respectively. Dyslipidemia could set in from 1 to 6 months of HAART usage in HIV-1 Positive subjects hence serum lipids should be monitored as early as one month of HAART commencement. Keywords : Dyslipidemia, HIV chemotherapy (HAART), Lipid profile, HIV

Dyslipidemia in HIV-1 Infected Subjects with Short Term Usage of Highly Active Antiretroviral Therapy (HAART) in Benin City, Nigeria